Differences in saliva ACE2 activity among infected and non-infected adult and pediatric population exposed to SARS-CoV-2
Daniel Jiménez(Centro de Investigación Biomédica en Red), Sergio Serrano‐Villar, Matilde Sánchez‐Conde, Cristina Calvo(Hospital Universitario La Paz), Elena Moreno(Instituto de Salud Carlos III), Daniel Blázquez‐Gamero(Research Institute Hospital 12 de Octubre), Javier Martínez‐Sanz(Instituto de Salud Carlos III), Manuel Ferrer(Instituto de Catálisis y Petroleoquímica), Robert B. Jenkins(Dartmouth–Hitchcock Medical Center), Mario Rodríguez-Domínguez(Instituto Cajal), Ana Méndez‐Echevarría(Hospital Universitario La Paz), Francesca Norman(Instituto Cajal), Raquel Ron(Universidad de Alcalá), Pilar Vizcarra(Universidad de Alcalá), Santiago Moreno(Universidad El Bosque), Talía Sainz(Hospital La Paz Institute for Health Research)
Cited by 11
Related Papers
Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402
|Journal of Clinical Oncology|2012|1.2k
The Global Phosphorylation Landscape of SARS-CoV-2 Infection
|Cell|2020|1.2k